TRYG Tryg A/S

Tryg A/S publishes Q2 and H1 results 2020 and hosts a conference call on 9 July 2020

Tryg A/S publishes Q2 and H1 results 2020 and hosts a conference call on 9 July 2020

Conference call

Tryg hosts a conference call on the day of the release at 10:00 CEST. CEO Morten Hübbe and CFO Barbara Plucnar Jensen will present the results in brief followed by a Q&A session.

The conference call will be held in English.

Date9 July 2020
Time10:00 CEST
Dial-in numbers    (DK)

+44 (0) 333 300 9031 (UK)

(US)

You can sign up for an e-mail reminder on . The conference call will also be broadcasted on this site. An on-demand version will be available shortly after the conference call has ended.



All Q2 and H1 material can be downloaded on shortly after the time of release.

Attachment

EN
25/06/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tryg A/S

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

Insurance trip: 16 insurers in three days

Non-life have price increases > inflation in all markets, most in Norway. Life insurance growth with rapid growth & dividend payments. Prefer ALMB, Sampo, Solid, Tryg among non-life; STB for life

Tryg AS: 2 directors

Two Directors at Tryg AS sold 65,000 shares at between 149.720DKK and 149.964DKK. The significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

Håkon Astrup
  • Håkon Astrup

Tryg (Buy, TP: DKK185.00) - Earnings momentum still solid

Through both favourable weather and narrowing credit spreads, Q1 PTP was 48% higher YOY. Recent repricing efforts continue to take effect, as seen in a 0.3%-points improved underlying claims ratio YOY, although portfolio rebalancing weighed somewhat on growth. Supported by an outlook for abating motor claims pressure, we continue to find the investment case favourable. Having made limited EPS revisions for 2026–2027e, we reiterate our BUY and DKK185 target price.

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland
ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

PTP beat from financials, UW inline

PTP beat from better financials, UW inline or a tad better. Reiterate '27 guidance and '25 premium growth from private/SMEs. Stock to outperform 1-3%; cons.est.rev. minor; strong read-x to GJF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch